What is the equity of Codexis this year?
Codexis has equity of 86.61 M USD this year.
Codexis Equity 2025
Codexis Equity
86.61 M USD
Ticker
CDXS
ISIN
US1920051067
WKN
A0Q2S4
In 2025, Codexis's equity was 86.61 M USD, a -40.18% increase from the 144.8 M USD equity in the previous year.
Codexis Aktienanalyse
What does Codexis do?
Codexis Inc. is an American biotechnology company that specializes in developing innovative biological solutions for a variety of industries. The company was founded in 2002 and is headquartered in Redwood City, California. Business Model: Codexis is service-oriented and provides customized enzyme solutions for companies looking to improve their products through sustainable processes. The company has developed a unique platform called Rational Protein Engineering, which allows for the development of specific enzymes for various industries. Customers benefit from enzyme optimization expertise and know-how. Divisions: Codexis operates in the fields of life sciences, materials science, agrochemicals, and biofuels. 1. Life Sciences: Codexis specializes in the production of enzymes and biocatalysts for the pharmaceutical industry in the life sciences division. The goal is to provide a faster and more efficient manufacturing process for pharmaceutical active ingredients. The company has successfully developed active ingredients for antibodies, lipids, uric acid, and antivirals. 2. Materials Science: In the materials science division, Codexis specializes in the production of enzymes for materials such as dyes, polymers, and cosmetic products. Codexis ensures that these products are efficiently manufactured without the use of environmentally harmful chemicals. 3. Agrochemicals: Codexis offers customized enzyme solutions to agrochemical manufacturers that reduce the use of chemicals and benefit the environment. These enzymes help in the production of pesticides and other agrochemicals. 4. Biofuels: In the biofuels division, Codexis specializes in the production of enzymes for processing corn, harvested plants, or waste products. These enzymes help enable cost-effective biofuel production. Products: Codexis has developed a wide range of products tailored to the needs of various industries. Some of the products recently introduced to the market by Codexis include: 1. CodeEvolver: CodeEvolver is a platform that allows biotechnology companies to quickly create customized enzyme solutions for their specific needs. The process is fully automated and results in a significant reduction in development time and costs. 2. Codex® screening panels: Codexis offers various screening panels that allow customers to quickly and efficiently select the enzymes best suited for their purposes. The panels are suitable for industries including pharmaceuticals, chemicals, and plant protection. 3. Codex® enzymes: Codexis offers a wide range of enzymes specifically designed for different industry needs. This includes enzymes for the production of biofuels, pesticides, cosmetic products, and pharmaceuticals. Overall, Codexis Inc. has demonstrated its ability to deepen the understanding of biocatalysts and introduce innovative biological processes in a variety of industries through its unique Rational Protein Engineering platform. Codexis ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Codexis's Equity
Codexis's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Codexis's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Codexis's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Codexis's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Codexis’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Codexis stock
What was the equity of Codexis compared to the previous year?
The equity of Codexis has increased/decreased by -40.18% decreased compared to the previous year.
What impact does a high equity have on investors of Codexis?
A high equity is advantageous for investors of Codexis as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Codexis?
A low equity can be a risk for investors of Codexis, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Codexis affect the company?
An increase in equity of Codexis can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Codexis affect the company?
A reduction in equity of Codexis can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Codexis?
Some factors that can affect the equity of Codexis include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Codexis so important for investors?
The equity of Codexis is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Codexis take to change the equity?
To change equity, Codexis can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Codexis pay?
Over the past 12 months, Codexis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Codexis is expected to pay a dividend of 0 USD.
What is the dividend yield of Codexis?
The current dividend yield of Codexis is .
When does Codexis pay dividends?
Codexis pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Codexis?
Codexis paid dividends every year for the past 0 years.
What is the dividend of Codexis?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Codexis located?
Codexis is assigned to the 'Health' sector.
Wann musste ich die Aktien von Codexis kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Codexis from 1/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/27/2025.
When did Codexis pay the last dividend?
The last dividend was paid out on 1/27/2025.
What was the dividend of Codexis in the year 2024?
In the year 2024, Codexis distributed 0 USD as dividends.
In which currency does Codexis pay out the dividend?
The dividends of Codexis are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Codexis
Our stock analysis for Codexis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Codexis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
